African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5136

Full Length Research Paper

Antimicrobial resistance pattern of Acinetobacter spp. isolated from clinical samples in a tertiary care hospital at Madinah, Saudi Arabia

Samah Ghanem
  • Samah Ghanem
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, P. O. Box 3893, Kingdom of Saudi Arabia.
  • Google Scholar
Hatem M. El Shafey
  • Hatem M. El Shafey
  • Department of Respiratory Therapy, College of Medical Rehabilitation Sciences, Taibah University, P. O. Box 3893 Madinah, Kingdom of Saudi Arabia.
  • Google Scholar
Nikhat Manzoor
  • Nikhat Manzoor
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, P. O. Box 3893, Kingdom of Saudi Arabia.
  • Google Scholar


  •  Received: 23 May 2018
  •  Accepted: 31 July 2018
  •  Published: 14 August 2018

 ABSTRACT

Multidrug resistance, in rapidly spreading bacterial species, is a matter of concern in health care units. Samples (6840) collected from a Saudi hospital in Madinah, were screened for Acinetobacter spp. and studied for frequency, gender distribution, and seasonal variations besides antimicrobial resistance pattern. Acinetobacter strains represented 5.5% of the clinical isolates from different sources. Of these, 63% were recovered from male samples. The largest numbers of these organisms were isolated from sputum and wound swabs representing about 85% of the samples. Antimicrobial sensitivity pattern showed that colistin was the most effective drug since it inhibited 76% of the Acinetobacter isolates. The remaining drugs did not reveal sensitivity greater than 15%. Results suggest colistin to be a promising drug in the treatment of Acinetobacter infections. It was also observed that percentage of these infections was highest during summers representing 39.15%, followed by autumn (28.17%) and winters (26.48%), while spring season recorded the least percentage with only 6.2% of infections. The present study was an attempt to generate data on the prevalence of resistance pattern and management of Acinetobacter infections.

 

Key words: Acinetobacter, antimicrobial sensitivity pattern, multidrug resistance, nosocomial infections.


 INTRODUCTION

Acinetobacter species  are  gram  negative  bacteria  that belong to  the family Moraxellaceae. These encapsulated
 
cocco-bacilli rods are non-motile, aerobic and do not ferment glucose. They test positive for catalase and citrate but negative for indole and oxidase (Manchanda et al., 2010; Almasaudi, 2018). They generally form part of the normal body flora but can cause a wide variety of local and systemic infections like pneumonia, septicemia and wound infections (Beggs et al., 2006; Almasaudi, 2018). The species can often be isolated from reusable medical equipments such as ventilator tubing, artificial pressure monitoring devices, humidifiers and wash basins. Gram-negative bacteria have the ability to acquire drug resistance genes such as extended-spectrum-lactamases (ESBLs), AmpC-β-lactamase, and carbapenemases (Al-Arfaj et al., 2011; Bader et al., 2017).
 
Acinetobacter spp., especially A. baumannii, have been described as the leading nosocomial pathogen and is prevalent world-wide (Abbo et al., 2005; Kanafani and Kanj, 2014). It is responsible for high mortality rates in critically ill patients (Doughari et al., 2011). It is found more frequently in hospital ICUs, than Staphylococcus aureus and Pseudomonas spp. (Almasaudi, 2018). A. baumannii is considered the “red alert” pathogen by the Infectious Diseases Society of America as it has significantly threatened the efficacy of the present antibacterial (Peleg et al., 2008). Several cases of drug resistant A. baumannii have been reported from hospitals in UAE, Bahrain, Saudi Arabia, Palestine and Lebanon (Almasaudi, 2018). Studies have shown that the most frequently isolated organism from ICU patients of tertiary care hospitals in Riyadh, Saudi Arabia is A. baumannii (Saeed et al., 2010; Kamolvit et al., 2015). High infection rates have been reported from the southern region of Saudi Arabia (Al Bshabshe et al., 2016; Almaghrabi et al., 2018).
 
At present, antibiotics are used frequently in diverse fields. They are prescribed to take care of unwanted infections that may occur during surgeries, organ transplants, and for the treatment of chronic infections (Teillant et al., 2015). Antibiotics are also used in animal husbandry and agriculture. To be precise, knowingly or unknowingly, there is exposure to different antibiotics which besides being toxic lead to multidrug resistance (MDR) and high treatment expenditures (Zowawi, 2016). MDR has already become a health issue at global level and it has been estimated that by the year 2050 it will be the leading cause of maximum deaths. MDR is common in Gram-negative bacteria and unfortunately there is scarcity of drugs that can provide effective treatment (Prestinaci et al., 2015). Contemporary studies from Middle East have shown that MDR in microbes is increasing extensively (Alawi and Darvesh, 2016). Carbapenem-resistant A. baumannii from Saudi Arabia have also increased dramatically over the years (Zowawi, 2016). A recent study showed that Saudi diabetic patients were   significantly   more   likely   to   carry  carbapenem-resistant isolates of this species (Alsultan et al. 2013). It has now become crucial to deal with MDR and this is possible by first being aware of the perils involved and then formulating and complying with appropriate guidelines (Baadani et al., 2015; Al-Harthi et al., 2015). The present study is an effort to determine the prevalence and antimicrobial susceptibility pattern of Acinetobacter spp. from clinical sources at a busy hospital in Madinah, Saudi Arabia.


 MATERIALS AND METHODS

Sample collection
 
Different clinical samples such as sputum, wound swab, bile, tracheal aspirate (Tr. asp.), throat aspirate (Th. asp.), catheter tip, pus, abdominal abscess (Abd. ab.), ear swab, peritoneal wound swab (Peri. w.s.), pleural fluid (Pler. fluid), vaginal swab (VS), urethral discharge (UD), eye cornea swab (ECS), bone tissues, and brain tube were collected from 6840 patients suspected of nosocomial bacterial infection at King Fahd Hospital at Madinah, Saudi Arabia according to Centers for Disease Control and Prevention Specimen Collection Guidelines (CDCP, 2013). Demographic data such as sex of the patients was recorded prior to sample collection.
 
Culture and Identification
 
The clinical samples were collected, aseptically inoculated on plates of blood agar, chocolate agar, cystine-lactose-electrolyte-deficient (CLED) agar and MacConkey agar (Oxoid Cambridge, UK) and incubated at 37°C for 24 h. Identification was done based on morphological characteristics of the colonies including size, shape, colour, pigmentation and haemolytic nature (Cheesbrough, 2006).
 
Biochemical characteristics
 
Suspected colonies of Acinetobacter were further identified through biochemical tests (Barrow and Felthan, 2003) using standard procedures and Phoenix automated microbiology 100 ID/AST system (Becton Dickinson Company, Sparks, Md.).
 
 
Antimicrobial susceptibility test
 
Susceptibility to antimicrobial agents was determined by using the disk diffusion method (Oqunshe, 2006), and Phoenix automated microbiology 100 ID/AST system (Becton Dickinson Company, Sparks, Md.). The following antimicrobial agents (obtained from BDH London, UK) were used: augmentin [amoxycillin + clavulinic acid (20/10 μg)], gentamycin (10 μg), cefoxitin (30 µg), cephalothin (30 µg), cotrimoxazole [trimethoprim-sulfamethoxazole 1:19 (25 µg)], amikacin (30 µg), ceftazidime (30 µg), aztreonam (30 µg), piperacillin (100 µg), imipenem (10 µg), ciprofloxacin (5 µg), cefpiramide (30 μg), tazobactam (10 µg), colistin(10 µg), and tigecycline (15 µg). The inocula were prepared by growing the strains on separate agar plates and colonies from the plates were transferred with a loop into 3 ml of normal saline. The density of these suspensions was adjusted to 0.5 McFarland standard. The surface of Muller-Hinton agar (Oxoid Cambridge, UK) plate was evenly inoculated with the organisms using sterile swabs. The swab was dipped into the suspension and pressed against the side of the test tube to remove excess fluid. The wet swab was then used to inoculate the Muller-Hinton agar by evenly streaking across the surface. By means of a Disc Dispenser (Oxoid Cambridge, UK), the antibiotic discs were placed on the surface of the inoculated agar and the plates were incubated overnight at 37°C. The diameter of zone of growth inhibition observed was measured and compared to the chart provided by Clinical and Laboratory Standards Institute (CLSI, 2017).


 RESULTS AND DISCUSSION

Due to ever increasing drug resistance, not many effective antimicrobials are available for the treatment of nosocomial Acinetobacter infections. Hence, there is an ardent need to develop new drugs and re-evaluate older antimicrobial therapies (Jain and Danziger, 2004). The risk factors that lead to infection with resistant Acinetobacter spp. are: prolonged stay in hospital (especially ICUs), mechanical ventilation, exposure to antimicrobial agents especially carbapenems, recent surgeries, invasive procedures and chronic illnesses (Manchanda et al., 2010). Self-medication and careless prescriptions given by doctors make matters worse. Several studies have reported the antimicrobial resistance patterns in Saudi Arabia, but there are only a few reports from Mecca and Madinah (Rotimi et al., 1998; Al-Johani et al., 2010; Zowawi, 2016). These two cities are visited by a large population of pilgrims every year. The present study is an endeavor to understand the resistance pattern of Acinetobacter spp. to several antimicrobial drugs. Frequency, gender distribution and seasonal variations were also studied with respect to infection caused by these bacteria.
 
Figure 1 shows the percentage of Acinetobacter spp. in comparison to other clinical isolates. These bacterial species comprised 5.5% (379 strains) of the total isolates; 62.8% (238 strains) were from male patients and 37.2% (141 strains) were from female patients (Figure 2). A higher number of isolates from male patients indicate greater prevalence of these infections in males than females. This pattern has also been displayed in several previous studies (Abbo et al., 2005; Masoud et al., 2011; Magliano et al., 2012; Howard et al., 2012; Haseeb et al., 2016). Figure 3 shows the percentage of Acinetobacter spp. recovered from various clinical sources. Pus, bile, ascitic fluid, vaginal swabs, urethral discharge, semen, bone tissue, appendix, gall bladder aspirates, cystic fluid, necrotic   tissue   were   some   samples  from  which  the Acinetobacter spp.  were not recovered. Majority of the isolates were from sputum (54.1%) and wound swabs (30.34%). Catheter tips, throat aspirates, tracheal aspirates and cerebrospinal fluids constituted 6.07, 3.43, 2.64 and 1.32%, respectively. Abdominal abscess and pleural fluid contributed only 0.53% each while ear swabs, peritoneal wound swabs and brain tube each provided the lowest percentage of 0.26%.
 
 
Table 1 provides an estimation of the gender distribution of samples isolated from different sources. As mentioned above, the major sample sources of the Acinetobacter spp. were sputum and wound swabs comprising 84.44% of the isolates. Out of 205 sputum samples, 59% were from males and 41% were from females. In the case of wound swabs (115 samples), 64.3% were from males and 35.7% were from females. Similarly, in case of cerebrospinal fluid and tracheal aspirates, although the samples were less in number, the male to female percentage ratio was 80:20. In case of catheter tips, again 74% samples were from males and 26% were from females. Only 13 samples were available from throat aspirates and were in the ratio of 53.8 males to 46.2 females. Pleural fluid provided only 2 strains, one  each  from  male  and  female. Ear, peritoneal wound swab, eye cornea swab and brain tubes provided only 1 sample each and that also from males. As the sample number from these sources was low, significant conclusions could not be drawn from them. The results hence indicated that males are more prone to infection than females. Lifestyle differences of both the genders and social and economic factors have an influence on the infection pattern. In Saudi Arabia, since women live a protected life usually indoors, their chance of acquiring bacterial infections is usually low in comparison to males. This pattern has been reported by other researchers as well (Haseeb et al., 2016; Magliano et al., 2012).
 
 
Antimicrobial drug susceptibility pattern of Acinetobacter spp. was assessed for 15 antimicrobial drugs listed in Table 2. All the drugs showed low sensitivity for Acinetobacter. Highest sensitivity was shown by colistin (76%), followed by amikacin (14.78%), gentamycin (12.9%) and imipenem (10.82%). For the remaining antimicrobials, the percentage was below 7% being significantly low. Highest resistance was shown towards cephalothin (99.74%), tazobactam (99.48%), augmentin (99.21%) and cefoxitin (99.21%). The percentage resistance of Acinetobacter spp. for other antimicrobials was  in the following order: tigecycline (98.96%) > ceftazidime (98.42%) > cefpiramide (98.42%) > ciprofloxacin (98.15%) > aztreonam (97.89%) > piperacillin (97.63%) > cotrimazole (93.14%) > imipenem (89.18%) > gentamycin (87.1%) > amikacin (85.22%). Colistin showed comparatively low resistance of only 24%. The results of the present study are coordination with the previous findings (Fishbain and Peleg, 2010). A study conducted in the southern region of Saudi Arabia showed that 74% of Acinetobacter isolates had MDR of which 50% were sensitive to colistin. These were resistant to all the other antimicrobials studied (Falagas et al., 2015; Almaghrabi et al., 2018).
 
Bacterial infections occur throughout the year but show seasonal variations depending upon several factors (Fares, 2013). These factors have to be explored to understand the prevalence and prognosis of the infections and to evolve novel and improved infection control strategies. There are several reports claiming that bacterial infections always peak during summers and winters (Perencevich et al., 2008; Eber et al., 2011; Richet, 2012). Table 3 shows the infection pattern of Acinetobacter during four different seasons of  the   year   in   the   city   of   Madinah.
 
 
Infections occurred with highest frequency in summers at 39.15 %. In winter season the infection was comparatively low (26.48 %). This maybe because the autumn season, that follows winters, coincides with the annual Hajj pilgrimage. This season experiences a huge influx of people into the two holy cities of Makkah and Madinah. During this event special care is taken by the health authorities to monitor and control any outbreak. As a result, low percentage of infections is recorded. A pattern of high infection rates in summers followed by slightly lower rates in the pilgrimage season have also been observed in the case of other Gram negative bacteria namely Proteus (Bahashwan and Shafey, 2013), Klebsiella (Ghanem et al., 2017), Pseudomonas (Saeed et al., 2018a) and E. coli (Saeed et al., 2018b) during the same period of study.
 
The two holy cities of Makkah and Madinah are visited by people from all around the world for Umrah and Hajj. Although Hajj is performed in a particular season, Umrah is performed all year round. It is a huge challenge for health authorities to keep infections under control. The enormous amount of people visiting at the same time from different places can lead to uncontrollable epidemics. Special precautions taken by the health care authorities help to keep infections and antimicrobial drug resistance in control. Several infection control programs are being implemented like the World Health Organization (WHO) hand hygiene program, the Gulf Cooperation Council (GCC) Infection Control Program (Yezli et al., 2014) and the antimicrobial stewardship program (Alawi and Darwesh, 2016; Zowawi, 2016). These programs are well coordinated into providing safe and cost-effective strategies for improved patient outcomes and reduced antimicrobial resistance.
 

 


 CONCLUSION

Sputum samples followed by wound swabs were found to be the largest source of Acinetobacter isolates. Samples isolated from male patients were a greater source in comparison to the female patients, maybe because males are at a greater risk to infection, being the main work force in Saudi Arabia. None of the tested antimicrobials showed 100% sensitivity. The highest sensitivity   was  shown  by  colistin  at  76%  followed  by amikacin, gentamycin and imipenem. The rest of the antimicrobials showed a sensitivity of less than 7%. Highest resistance was displayed by cephalothin, tazobactum, augmentin and cefoxitin in the same order. These antimicrobials should be prescribed with care. The infections occurred with highest frequency in summers and lowest in spring. The frequency dropped in autumn as it coincided with the Hajj season when authorities are extra cautious. The present study will help in generating local database that can be used for formulating infection control strategies in this area, especially during pilgrimage season. People should get appropriate education on the issue of MDR, especially physicians who should develop a sense of responsibility while prescribing antibiotics. Similar studies will contribute towards creation of effective guidelines and infection control programs.


 CONFLICT OF INTERESTS

The authors have not declared any conflict of interests.


 ACKNOWLEDGEMENTS

The authors would like to thank the Microbiology staff of King Fahd Hospital, Al Madinah Al Munawarah, Saudi Arabia for their assistance with data collection.



 REFERENCES

Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005). Multidrug-resistant Acinetobacter baumannii. Emerging Infectious Diseases 11:22-29.
Crossref

 

Al Bshabshe A, Joseph MRP, Al Hussein A, Haimour W, Hamid ME (2016). Multidrug resistance Acinetobacter species at the intensive care unit, Aseer Central Hospital, Saudi Arabia: A one year analysis. Asian Pacific Journal of Tropical Medicine 9(9):903-908.
Crossref

 
 

Al-Arfaj AA, Ibrahim ASS, Somily AM, Al Salamah AA (2011). Genetic basis of carbapenem resistance in Acinetobacter clinical isolates in Saudi Arabia. African Journal of Biotechnology 10(64):14186-14196.

 
 

Alawi MM, Darwesh BM (2016). A stepwise introduction of a successful antimicrobial stewardship program: Experience from a tertiary care university hospital in Western, Saudi Arabia. Saudi Medical Journal 37(12):1350-1358.
Crossref

 
 

Al-Harthi SE, Khan LM, Osman A-MM, Alim MA, Saadah OI, Almohammadi AA, Khan FM, Kamel FO (2015). Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia. Saudi Medical Journal 36:813-820.
Crossref

 
 

Al-Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z (2010). Prevalence of antimicrobial resistance among Gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Annals of Saudi Medicine 30(5):364-369.
Crossref

 
 

Almaghrabi MK, Joseph MRP, Assiry MM, Hamid ME (2018). Multidrug-Resistant Acinetobacter baumannii: An Emerging Health Threat in Aseer Region, Kingdom of Saudi Arabia. Canadian Journal of Infectious Diseases and Medical Microbiology 2018(9182747):1-4.
Crossref

 
 

Almasaudi SB (2018). Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi Journal of Biological Sciences 25:586-596.
Crossref

 
 

Alsultan AA, Evans BA, Elsayed EA, Al-Thawadi SI, Al-Taher AY, Amyes SGB, Al-Dughaym AM, Hamouda A (2013). High frequency of carbapenem-resistant Acinetobacter baumanniiin patients with diabetes mellitus in Saudi Arabia. Journal of Medical Microbiology 62:885-888.
Crossref

 
 

Baadani AM, Baig K, Alfahad WA, Aldalbahi S, Omrani AS (2015). Physicians' knowledge, perceptions, and attitudes toward antimicrobial prescribing in Riyadh, Saudi Arabia. Saudi Medical Journal 36:613-619.
Crossref

 
 

Bader MS, Loeb M, Brooks AA (2017). An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate Medical 129(2):242-258.
Crossref

 
 

Bahashwan SA, El Shafey HM (2013). Antimicrobial resistance patterns of Proteus isolates from clinical specimens. European Scientific Journal 9(27):188-202.

 
 

Barrow GI, Felthan RKA (2003). Cowan and Steel's Manual for the Identification of Medical Bacteria. 3rd Ed. Cambridge University Press. Cambridge UK. pp. 351-353.

 
 

Beggs C, Kerr K, Snelling A, Sleigh P (2006). Acinetobacter spp. and the clinical environment. Indoor and Built Environment 15:19-24.
Crossref

 
 

Center for Disease Control and Prevention (CDCP) (2013). Office of Infectious Disease Antibiotic resistance threats in the United States.

 
 

Cheesbrough M (2006). District Laboratory Practice in Tropical Countries Part-2. 2nd Edition, Cambridge University Press.
Crossref

 
 

Clinical and Laboratory Standards Institute (CLSI) (2017). Performance standards for antimicrobial disk susceptibility tests, 27th ed. Approved standard M02-A12.Wayne, Pa.

 
 

Doughari HJ, Ndakidemi PA, Human IS, Benade S (2011). The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes and Environments 26(2):101-12.
Crossref

 
 

Eber MR, Shardell M, Schweizer ML, Laxminarayan R, Perencevich EN (2011). Seasonal and temperature-associated increases in Gram negative bacterial bloodstream infections among hospitalized patients. PLoS One 6(9):e25298.
Crossref

 
 

Falagas ME, Vardakas KZ, Roussos NS (2015). Trimethoprim/ sulfamethoxazole for Acinetobacter spp.: a review of current microbiological and clinical evidence. International Journal of Antimicrobial Agents 46 (3):231-241.
Crossref

 
 

Fares A (2013). Factors Influencing the seasonal patterns of infectious diseases. International Journal of Preventive Medicine 4(2):128-132.

 
 

Fishbain J, Peleg AY (2010). Treatment of Acinetobacter infections. Clinical Infectious Diseases 51(1):79-84.
Crossref

 
 

Ghanem S, El Shafey HM, El Kelani TA, Manzoor N (2017). Antimicrobial resistance patterns of Klebsiella isolates from clinical samples in a Saudi hospital. African Journal of Microbiology Research 11(23):965-971.
Crossref

 
 

Haseeb A, Faidah HS, Bakhsh AR, Malki WH, Elrggal ME, Saleem F, Rahman SU, Khan TM, Hassali MA (2016). Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia. International Journal of Infectious Diseases 47:92-94.
Crossref

 
 

Howard A, O'Donoghue M, Feeney A, Sleator RD (2012). Acinetobacter baumannii: An emerging opportunistic pathogen. Virulence 3(3):243-250.
Crossref

 
 

Jain R, Danziger LH (2004). Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Annals of Pharmacotherapy 38:1449-1459.
Crossref

 
 

Kamolvit W, Sidjabat HE, Paterson DL (2015). Molecular epidemiology and mechanisms of carbapenem resistance of Acinetobacter spp. in Asia and Oceania. Microbial Drug Resistance 21:424-434.
Crossref

 
 

Kanafani ZA, Kanj SS (2014). Ministry of Health, Kingdom of Saudi Arabia. http://www.uptodate.com/contents/acinetobacter-infection-treatment-and-prevention.

 
 

Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P (2012). Gender and Age-dependent etiology of community-acquired urinary tract infections. Science World Journal 2012:1-6.
Crossref

 
 

Manchanda V, Sanchaita S, Singh NP (2010). Multidrug Resistant Acinetobacter. Journal of Global Infectious Diseases 2(3): 291-304.
Crossref

 
 

Masoud EA, Mahdy ME, Esmat AM (2011). Bacterial Prevalence and Resistance to Antimicrobial Agents in Southwest, Saudi Arabia. Egyptian Academic Journal of Biological Sciences 3(1):105-111.

 
 

Oqunshe AAO (2006). In vitro phenotypic antibiotic resistance in bacterial flora of some indigenous consumed herbal medications in Nigeria. Journal of Rural and Tropical Public Health 5:9-15.

 
 

Peleg AY, Seifert H, Paterson DL (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clinical Microbiology Reviews 21:538-582.
Crossref

 
 

Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG Jr, Fisman DN, Johnson JA (2008). Summer Peaks in the Incidences of Gram-Negative Bacterial Infection Among Hospitalized Patients. Infection Control and Hospital Epidemiology 29(12):1124-1131.
Crossref

 
 

Prestinaci F, Pezzotti P, Pantosti A (2015). Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and Global Health 109(7):309-318.
Crossref

 
 

Richet H (2012). Seasonality in Gram-negative and healthcare-associated infections. Clinical Microbiology and Infection 18(10):934-40.
Crossref

 
 

Rotimi VO, Al-Sweih NA, Feteih J (1998). The prevalence and antibiotic susceptibility pattern of Gram negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diagnostic Microbiology and Infectious Disease 30:53-59
Crossref

 
 

Saeed NK, Kambal AM, El-Khizzi NA (2010). Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Medical Journal 31:1341-1349.

 
 

Saeed WM, Ghanem S, El Shafey HM, Manzoor N (2018a). In vitro antibiotic resistance patterns of Pseudomonas spp. isolated from clinical samples of a hospital in Madinah, Saudi Arabia. African Journal of Microbiology Research 12(1):19-26.
Crossref

 
 

Saeed WM, Ghanem S, El Shafey, HM, Manzoor N (2018b). Assessment of antimicrobial resistance patterns in Escherichia coli isolated from clinical samples in Madinah, Saudi Arabia. African Journal of Microbiology Research 12(13):321-326.
Crossref

 
 

Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R (2015). Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. The Lancet Infectious Diseases 15(12):1429-37.
Crossref

 
 

Yezli S, Shibl AM, Livermore DM, Memish ZA (2014). Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia. Journal of Chemotherapy 26(5):257-272.
Crossref

 
 

Zowawi HM (2016). Antimicrobial resistance in Saudi Arabia: An urgent call for an immediate action. Saudi Medical Journal J. 37(9):935-940.
Crossref

 

 




          */?>